Blurbs

Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Sangamo Biosciences (SGMO) and Siemens Healthineers AG (OtherSEMHF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Qiagen (QGENResearch Report), Sangamo Biosciences (SGMOResearch Report) and Siemens Healthineers AG (SEMHFResearch Report).

Qiagen (QGEN)

In a report released today, Peter Welford from Jefferies maintained a Hold rating on Qiagen, with a price target of EUR42.00. The company’s shares closed last Monday at $41.93, close to its 52-week low of $40.38.

According to TipRanks.com, Welford is a 5-star analyst with an average return of 10.8% and a 54.2% success rate. Welford covers the Healthcare sector, focusing on stocks such as Roche Holding AG, GlaxoSmithKline, and Sanofi.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Qiagen with a $48.44 average price target, a 14.3% upside from current levels. In a report issued on October 24, Kepler Capital also maintained a Hold rating on the stock with a EUR50.00 price target.

See the top stocks recommended by analysts >>

Sangamo Biosciences (SGMO)

Wells Fargo analyst Yanan Zhu maintained a Buy rating on Sangamo Biosciences yesterday and set a price target of $20.00. The company’s shares closed last Monday at $3.39, close to its 52-week low of $3.12.

According to TipRanks.com, Zhu ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -14.6% and a 29.4% success rate. Zhu covers the Healthcare sector, focusing on stocks such as Applied Genetic Technologies, Aeglea Biotherapeutics, and Taysha Gene Therapies.

Currently, the analyst consensus on Sangamo Biosciences is a Moderate Buy with an average price target of $14.50, implying a 297.3% upside from current levels. In a report issued on November 4, RBC Capital also maintained a Buy rating on the stock with a $22.00 price target.

Siemens Healthineers AG (SEMHF)

Berenberg Bank analyst Odysseas Manesiotis maintained a Buy rating on Siemens Healthineers AG today and set a price target of EUR54.00. The company’s shares closed last Monday at $46.94.

According to TipRanks.com, Manesiotis is ranked #7601 out of 8026 analysts.

Currently, the analyst consensus on Siemens Healthineers AG is a Strong Buy with an average price target of $58.97, which is a 25.6% upside from current levels. In a report issued on October 27, Kepler Capital also maintained a Buy rating on the stock with a EUR55.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on QGEN:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More